Media Releases
Corporate News
February 08, 2012
FDA grants Roche's pertuzumab Priority Review for previously untreated HER2-positive metastatic breast cancer
Roche today announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s Biologics License ...
more
February 08, 2012
Roche disappointed by the actions of Illumina, Inc.'s Board of Directors
Roche released the following statement in response to the announcement by Illumina, Inc. that its Board of Directors has recommended ...
more
February 01, 2012
Roche in 2011: Strong results and positive outlook
Group sales rise 2% 1 (-10% in Swiss francs; +6% in US dollars), excluding Tamiflu; Significant foreign exchange impact of ...
more
January 31, 2012
Roche to nominate slate of independent directors for election at Illumina, Inc.'s 2012 annual meeting
Roche announced today that it has provided notice to Illumina, Inc. (NASDAQ: ILMN) that it will nominate a slate of highly ...
more
January 30, 2012
FDA approves Erivedge (vismodegib) capsule, the first medicine for adults with advanced basal cell carcinoma
Roche today announced that Erivedge (vismodegib) capsule was approved by the U.S. Food and Drug Administration (FDA) for adults ...
more
January 27, 2012
Roche commences tender offer for Illumina, Inc. for $44.50 per share in cash
Roche, a leader in research-focused healthcare with combined strengths in pharmaceuticals, life science tools and diagnostics, ...
more
January 27, 2012
Roche responds to adoption of shareholder rights plan by Illumina Board of Directors
Roche today responded to an announcement from Illumina, Inc. (NASDAQ: ILMN) that its Board of Directors has adopted a shareholder ...
more
January 25, 2012
Roche offers to acquire all outstanding shares of Illumina, Inc. to further strengthen its leading role in diagnostics
Roche announced today that it is proposing to acquire all outstanding shares of Illumina, Inc. (NASDAQ:ILMN) for $44.50 per ...
more
January 23, 2012
Roche supports cancer care development program in Ethiopia
Roche today announced a grant to the Albert Einstein College of Medicine of Yeshiva University in New York City, which will ...
more